Joan G. Meeder

ORCID: 0000-0003-3261-9361
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Imaging and Diagnostics
  • Atrial Fibrillation Management and Outcomes
  • Cardiac Arrhythmias and Treatments
  • Acute Myocardial Infarction Research
  • Cardiac electrophysiology and arrhythmias
  • Cardiovascular Function and Risk Factors
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Coronary Interventions and Diagnostics
  • Cardiac pacing and defibrillation studies
  • Advanced MRI Techniques and Applications
  • Health Systems, Economic Evaluations, Quality of Life
  • Heart Failure Treatment and Management
  • Cardiovascular Disease and Adiposity
  • Cardiovascular Health and Disease Prevention
  • Venous Thromboembolism Diagnosis and Management
  • Receptor Mechanisms and Signaling
  • Infective Endocarditis Diagnosis and Management
  • Cardiac Health and Mental Health
  • Cardiac Valve Diseases and Treatments
  • Cardiac, Anesthesia and Surgical Outcomes
  • Emergency and Acute Care Studies
  • Heart Rate Variability and Autonomic Control
  • Medical Imaging Techniques and Applications
  • Cardiovascular Syncope and Autonomic Disorders
  • Cerebrovascular and Carotid Artery Diseases

VieCuri Medisch Centrum
2014-2025

University of Belgrade
2017-2022

Maastricht University
2019

University Medical Center
2019

Centar za Promociju Nauke
2017

Medisch Spectrum Twente
2006

Elisabeth-TweeSteden Ziekenhuis
2006

Franciscus Vlietland
2006

Máxima Medisch Centrum
2006

St. Antonius Ziekenhuis
2006

Patients with recent-onset atrial fibrillation commonly undergo immediate restoration of sinus rhythm by pharmacologic or electrical cardioversion. However, whether is necessary not known, since often terminates spontaneously.

10.1056/nejmoa1900353 article EN New England Journal of Medicine 2019-03-18
Adam Timmis Victor Aboyans Panos E. Vardas Nick Townsend Aleksandra Torbica and 95 more Maryam Kavousi Giuseppe Boriani Radu Huculeci D Kazakiewicz Douglas S. Scherr Efstratios Karagiannidis Marta Cvijić Agnieszka Kapłon‐Cieślicka Barbara Ignatiuk Pekka Raatikainen Delphine De Smedt Angela Wood Dariusz Dudek Éric Van Belle Franz Weidinger B. Kichou Yasmina Bououdina Hamlet Hayrapetyan Hamayak Sisakian Marine Ordyan Bernhard Metzer Georg Delle‐Karth Ulvi Mirzoyev Rahimov Uzeyir Rahima Gabulova B. Gerber Zumreta Kušljugić Elnur Smajić Vassil Traykov Elena Dimitrova D Gencheva T. Yaneva Davor Miličić Hera Heracleous Eteokleous Nikos Petr Ošťádal Aleš Linhart Michael Rahbek Schmidt Märt Elmet Priit Kampus Mika Laine Tuomas Kiviniemi Matti Niemelä Bernard Iung Christophe Leclercq Holger Thiele Kurt Bestehorn Stephan Baldus George Kochiadakis Konstantinos Toutouzas John Kanakakis Dávid Becker Þórdís Jóna Hrafnkelsdóttir Helga Margret Skuladottir Pascal McKeown Barbra Dalton Amit Segev Ciro Indolfi Pasquale Perrone Filardi Fabrizio Oliva Berkinbayev Salim Bekbossynova Mahabbat Pashimov Marat Erkin М Мirrakhimov S. Abilova Kurban Kalysov Andrejs Ērglis Vilnis Dzerve Jelena Čelutkienė Tomas Lapinskas Cristiana Banu Robert G. Xuereb Tiziana Felice Philip Dingli Rudolf A. de Boer Joan G. Meeder Marijan Bosevski Jorgo Kostov Ole Christian Mjølstad Kristin Angel Robert Gil Przemysław Mitkowski Bohdan Maruszewski Hélder Pereira Jorge Ferreira Eduardo Infante de Oliveira Bogdan A. Popescu Ovidiu Chioncel Elisabeta Bădilă Archil Chukhrukidze Gani Bajraktari Pranvera Ibrahimi Ibadete Bytyçi M Popovíci Marina Foscoli

Abstract This report from the European Society of Cardiology (ESC) Atlas Project updates and expands upon 2021 in presenting cardiovascular disease (CVD) statistics for ESC member countries. paper examines inequalities healthcare outcomes countries utilizing mortality risk factor data World Health Organization Global Burden Disease study with additional economic Bank. Cardiovascular were collected by questionnaire circulated to national cardiac societies Statistics pertaining 2022, or latest...

10.1093/eurheartj/ehae466 article EN other-oa European Heart Journal 2024-08-27

Patients with angina and no obstructive coronary artery disease frequently have vasomotor dysfunction as underlying pathophysiological mechanism, comprising epicardial spasm, microvascular and/or microcirculatory dysfunction. These endotypes can be diagnosed by invasive function testing which has previously shown to safe in tertiary expert centers. To determine the prevalence of patients who were clinically referred for a test (CFT); assess safety feasibility CFT. This quality improvement...

10.1001/jamacardio.2024.5670 article EN cc-by JAMA Cardiology 2025-02-19

Background A coronary function test (CFT) is the recommended diagnostic to identify vasomotor dysfunction as a cause of symptoms in patients with angina and nonobstructive arteries (ANOCA). Acetylcholine commonly used pharmacological agent for spasm provocation. We aimed investigate an association between severity provocative acetylcholine dose. Methods Results included ANOCA undergoing clinically indicated CFT from Netherlands Registry Invasive Coronary Vasomotor Function Testing: NL‐CFT....

10.1161/jaha.124.037913 article EN cc-by-nc-nd Journal of the American Heart Association 2025-01-17

BackgroundAngina without angiographic evidence of obstructive coronary artery disease (ANOCA) is a highly prevalent condition with insufficient pathophysiological knowledge and lack evidence-based medical therapies. This affects ANOCA patients prognosis, their healthcare utilization quality life. In current guidelines, performing function test (CFT) recommended to identify specific vasomotor dysfunction endotype. The NetherLands registry invasive Coronary Function testing (NL-CFT) has been...

10.1016/j.ijcard.2023.02.043 article EN cc-by-nc-nd International Journal of Cardiology 2023-02-28

Objective Presentations of non-cardiac chest pain (NCCP) to the emergency department (ED) are increasing. More knowledge prognosis and healthcare utilisation patients with NCCP is necessary optimise their management. Methods This study a prospective, observational, prevalence-based cohort conducted from September 2015 February 2016 1-year follow-up including all 18 years older referred ED pain. Discharge diagnoses, mortality, major adverse cardiac events (MACE), re-presentations ED,...

10.1136/openhrt-2018-000859 article EN cc-by-nc Open Heart 2018-10-01

<sec> <title>BACKGROUND</title> Mental stress is a well-known trigger of cardiac symptoms in patients with coronary artery spasms. Hence, management recommended beyond medical therapy. However, specific programs for spasms are lacking. We collaborated to develop smartphone-based application as tailored solution. The provides biofeedback based on HRV-driven level estimations. </sec> <title>OBJECTIVE</title> Our study aimed evaluate the effect biofeedback-driven smartphone women vasospasms....

10.2196/preprints.76146 preprint EN 2025-04-17

The fundamental abnormality in syndrome X (angina pectoris, ischaemia-like stress ECG despite angiographically normal coronary arteries) might be patchily distributed increased tone pre-arteriolar vessels with compensatory release of adenosine. aim this study was to confirm hypothesis and explore its relationships autonomic system functioning. Using parametric positron emission tomography, myocardial perfusion examined 480 segments 16 patients age- sex-matched healthy volunteers. Autonomic...

10.1093/oxfordjournals.eurheartj.a060780 article EN European Heart Journal 1995-11-01

Abstract Background The impact of overweight and obesity on outcomes in “real world” patients with atrial fibrillation (AF) is not fully defined. Second, sex differences AF may also exist. Methods results aim was to investigate at 1 year follow‐up for enrolled the EORP‐AF Registry, according BMI (kg/m 2 ), comparing normal (18.5 &lt; 25 kg/m (25 30 ) (≥ relation differences. Among 2,540 EORP (38.9% female; median age 69) data available, 720 (28.3%) had a BMI, 1,084 (42.7%) were overweight,...

10.1111/jce.13428 article EN Journal of Cardiovascular Electrophysiology 2018-01-18

Abstract Objectives Patients with acute coronary syndrome (ACS) should be referred promptly to the hospital reduce mortality and morbidity. Differentiating between low-risk high-risk patients remains a diagnostic challenge. Point-of-care testing can contribute earlier disposition decisions for excluded from ACS. This study describes validation of Atellica ® VTLi. Patient-side Immunoassay Analyzer high-sensitivity troponin point-of-care (POC) analysis. (The VTLi is not available sale in USA....

10.1515/cclm-2022-0268 article EN Clinical Chemistry and Laboratory Medicine (CCLM) 2022-07-21

Aims The characteristics of sensors to perform rate adaptive pacing are well established but whether their contribution improves health-related quality life (QoL) remains disputable. To compare the effects on QoL with an integrated dual sensor [minute ventilation (MV) and acceleration, TT sensor] a single MV sensor, no pacing. Methods results This Dutch multi centre, prospective, single- (patient) blind study was performed in patients after first pacemaker (PM) implant for sick sinus...

10.1093/europace/eum021 article EN EP Europace 2007-03-09

Abstract Purpose A 2D image navigator (iNAV) based 3D whole-heart sequence has been used to perform MRI and PET non-rigid respiratory motion correction for hybrid PET/MRI. However, only the data acquired during acquisition of is corrected motion. This study introduces evaluates an MRI-based method complete data. Methods Twelve oncology patients scheduled additional cardiac 18 F-Fluorodeoxyglucose ( F-FDG) PET/MRI 15 with coronary artery disease (CAD) F-Choline F-FCH) were included. iNAV...

10.1186/s40658-024-00637-z article EN cc-by EJNMMI Physics 2024-04-06

International guidelines recommend implantation of an implantable cardioverter-defibrillator (ICD) in non-ischaemic cardiomyopathy (NICM) patients with a left ventricular ejection fraction (LVEF) below 35% despite optimal medical therapy and life expectancy more than 1 year good functional status. We propose refinement these recommendations NICM, careful consideration additional risk parameters for both arrhythmic non-arrhythmic death. These include late gadolinium enhancement on cardiac...

10.1007/s12471-024-01859-7 article EN Netherlands Heart Journal 2024-04-18

Patients with stable chest pain suspected of coronary artery disease (CAD) usually undergo multiple diagnostic tests to confirm or rule out obstructive CAD. Some may not effectively assess the presence CAD, precluding optimal treatment. A strategy upfront computed tomography angiography (CTCA) combined medical therapy (OMT) tailored extent CAD be superior standard care in preventing major adverse cardiac events.

10.1007/s12471-024-01906-3 article EN Netherlands Heart Journal 2024-10-18

Abstract Background and purpose Patients with angina no obstructive coronary artery disease (ANOCA) frequently have vasomotor dysfunction (CVDys) as underlying pathophysiological mechanism, comprising epicardial spasm, microvascular spasm and/or microcirculatory dysfunction. These can be diagnosed by invasive function testing (CFT), which has previously shown to safe in tertiary expert centres. The prevalence of CVDys safety feasibility CFT is reported on this first national collaboration...

10.1093/eurheartj/ehae666.2362 article EN European Heart Journal 2024-10-01

To describe current evidence of the frequency, contents, and involved professionals routine follow-up visits in patients who have received a pacemaker (PM).The multicentre FOLLOWPACE study prospectively collected data during implantation 1526 PM for first time. A total 4914 were studied. Mean was 394 days with mean 3.2 per patient. At all visits, battery condition tested >93%, stimulation threshold >91%, sensing >87%. The parameters as thresholds, lead impedances, percentages pacing remained...

10.1093/europace/eun093 article EN EP Europace 2008-04-18
Coming Soon ...